Petros Pharmaceuticals Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,825 | -2,163 | -8,163 | -8,481 | -3,932 |
| Depreciation Amortization | N/A | N/A | 3,415 | 2,578 | 1,718 |
| Accounts receivable | N/A | N/A | -144 | -897 | -471 |
| Accounts payable and accrued liabilities | -212 | -48 | -93 | -451 | -23 |
| Other Working Capital | -32 | 17 | 625 | -1,117 | 674 |
| Other Operating Activity | 271 | 1,059 | -3,266 | 3,002 | 713 |
| Operating Cash Flow | $-2,797 | $-1,135 | $-7,627 | $-5,367 | $-1,320 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -1,464 | -1,090 | -721 |
| Other Financing Activity | -3,080 | -1,121 | 13,001 | 15,000 | 0 |
| Financing Cash Flow | $-3,080 | $-1,121 | $11,537 | $13,910 | $-721 |
| Beginning Cash Position | 13,337 | 13,337 | 9,426 | 9,426 | 9,426 |
| End Cash Position | 7,460 | 11,081 | 13,337 | 17,970 | 7,385 |
| Net Cash Flow | $-5,877 | $-2,256 | $3,911 | $8,544 | $-2,042 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,797 | -1,135 | -7,627 | -5,367 | -1,320 |
| Free Cash Flow | -2,797 | -1,135 | -7,627 | -5,367 | -1,320 |